NTI
NEUROTECH FPO [NTI]
Healthcare · ASX Small Cap
$0.0130 +0.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +12First seen: 2026-02-25
Score Breakdown
Technical34
Catalyst53
Sentiment50
Fundamental70
Momentum45
Risk Gate28
Active Signals
Bullish Signals
- Sustained volume spike (2.7x median) on DOWN trend
- Near support level (potential bounce)
- Volatility contracting (breakout setup)
- Strong cash runway (9 quarters)
- Low P/S ratio (2.4x)
- Strong revenue growth (+4069%)
- Near 52-week low (4% of range)
- Micro-cap ($5-20M) - high risk
- Strong revenue momentum (+4069%)
- Altman Z-Score in grey zone (2.09)
- Penny stock risk ($0.013)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE3 (est. 2026-05-01)
Risk Signals
- Price below MAs (downtrend)
- VPT distribution divergence (bearish)
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-54%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-48%)
Recent Catalysts
NONE Appendix 4D & Half Year Report
NONE Positive 90-day GLP toxicology study results in non-rodents
NONE NTI Collaborates with University of Sydney in Rett program
HIGH Approval received for NTI164 Phase 3 Clinical Study in ASD
Recent ASX Announcements
| 2026-02-26 | Appendix 4D & Half Year Report PRICE SENSITIVE |
| 2026-02-22 | Positive 90-day GLP toxicology study results in non-rodents PRICE SENSITIVE |
| 2026-02-17 | NTI Collaborates with University of Sydney in Rett program |
| 2026-02-10 | Notice of General Meeting/Proxy Form |
| 2026-02-01 | Approval received for NTI164 Phase 3 Clinical Study in ASD PRICE SENSITIVE |
Key Metrics
$16.9M
Market Cap
1.7M
Avg Volume
2.7x
Vol Ratio
$0.01 — $0.04
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-66.3%
ROE
-54.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 58% |
| L | Leader vs Laggard | laggard | RS: -6 |
| I | Institutional Sponsorship | weak | Inst: 3% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #21 of 119 · Sector avg: 51
View all Healthcare signals →